Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Real-World Outcomes of Ruxolitinib for Polycythemia Vera

Alexander Coltoff, MD, Douglas Tremblay, MD, Marina Kremyanskaya, MD PhD, Ronald Hoffman, MD, John Mascarenhas, MD

Blood (2017) 130 (Supplement 1): 2926.

https://doi.org/10.1182/blood.V130.Suppl_1.2926.2926

Published: 2017

Journal Articles

Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab

Carla Casulo, MD, Juan-Manuel Sancho, Koen Van Eygen, MD, Sven de Vos, MD PhD, Santiago Mercadal, MD, Roderick J. Johnson, MD, Kamal Bouabdallah, MD, Houston Holmes, MD FACP, Jan Lemmens, MD, Emmanuel Gyan, MD, Michele Merli, MD, Ranjana H Advani, MD, Lori Steelman, MA, Joseph Pearlberg, MD PhD, Andre Goy, MD

Blood (2016) 128 (22): 2979.

https://doi.org/10.1182/blood.V128.22.2979.2979

Published: 2016

Journal Articles

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Michael A Thompson, MD PhD, Martin K Oaks, PhD, John O Richards, PhD, Maharaj Singh, PhD, Thomas S Smith, BS, Karen M Michel, BS, Andinet W Alemu, MD, Michael P. Mullane, MD, Husam S Tarawneh, MD, Angela M Kraut, Kayla J Hamm, Carla Fuentes

Blood (2016) 128 (22): 5607.

https://doi.org/10.1182/blood.V128.22.5607.5607

Published: 2016

Journal Articles

Safety, Phamacokinetics (PK), Pharmacodynamics (PD) and Preliminary Activity in Acute Leukemia of Ory-1001, a First-in-Class Inhibitor of Lysine-Specific Histone Demethylase 1A (LSD1/KDM1A): Initial Results from a First-in-Human Phase 1 Study

Tim Somervaille, MD PhD, Olga Salamero, MD, Pau Montesinos, MD PhD, Christophe Willekens, MD, Jose Antonio Perez Simon, MD, Arnaud Pigneux, MD, Christian Recher, MD PhD, Rakesh Popat, Cesar Molinero, MD PhD, Christina Mascaro, PhD, Tamara Maes, PhD, Francesc Bosch, MD PhD

Blood (2016) 128 (22): 4060.

https://doi.org/10.1182/blood.V128.22.4060.4060

Published: 2016

Journal Articles

Burden of Pneumococcal Disease in Cancer Patients: A 20 Year Single Center Study at Memorial Sloan-Kettering Cancer Center

Yeon Joo Lee, MD MPH, Yao-Ting Hayden Huang, PhD MPH, Seong Jin Kim, MPH, Marina Kerpelev, Victoria Gonzalez, Genovefa A Papanicolaou, MD, Anna Kaltsas

Blood (2015) 126 (23): 3303.

https://doi.org/10.1182/blood.V126.23.3303.3303

Published: 2015

Journal Articles

Outcomes of Splenectomy in Children with Sickle Cell Disease

Peter B. Soh, M.P.H., Abdul H. Siddiqui, MBBS, MD

Blood (2014) 124 (21): 1382.

https://doi.org/10.1182/blood.V124.21.1382.1382

Published: 2014

Journal Articles

Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine

Kimberly Noonan, PhD, MPH, Lakshmi Rudraraju, MS, Anna Ferguson, RN, Amy Sidorski, NP, Andrea Casildo, BS, Ervin Griffin, Susan Lee, BS, Nilanjan Ghosh, MD, PhD, William Matsui, MD, Carol Huff, M.D., Ivan M. Borrello, MD

Blood (2013) 122 (21): 1980.

https://doi.org/10.1182/blood.V122.21.1980.1980

Published: 2013

Journal Articles

A Phase II Trial of TBL 12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma,

Ajai Chari, MD, Amitabha Mazumder, MD, Lauren Ditrio, Zachary Galitzeck, Sundar Jagannath, MD

Blood (2011) 118 (21): 3992.

https://doi.org/10.1182/blood.V118.21.3992.3992

Published: 2011

Journal Articles

A Phase II Trial of TBL 12 Sea Cucumber Extract In Patients Withuntreated Asymptomatic Myeloma

Amitabha Mazumder, MD, Ajai Chari, MD, Lauren Ditrio, Zachary Galitzeck, Sundar Jagannath, MD

Blood (2010) 116 (21): 5042.

https://doi.org/10.1182/blood.V116.21.5042.5042

Published: 2010

Journal Articles

Influenza (flu) Vaccine Administration to Patients with Multiple Myeloma (MM) Prior to Autologous T-Cell Harvest Leads to Better Reconstitution of Flu Immunity After High Dose Melphalan and Autologous Stem Cell Transplant (ASCT) and Reinfusion of Primed Ex-Vivo Co-Stimulated Autologous T-Cells and Post-ASCT Second Flu Vaccination Than Post-ASCT Flu Vaccination Alone.

Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Nicole A. Aqui, MD, Aaron P. Rapoport, MD, Kenyetta Macdonald, Heather Murphy, Rita Bhagat, RN, Patricia A. Mangan, APRN, BC, Anne Chew, PhD, Elizabeth Veloso, RN, JD, Bruce Levine, PhD, Robert H. Vonderheide, MD, DPhil, Carl H. June, MD, Kathleen Sullivan, MD

Blood (2009) 114 (22): 797.

https://doi.org/10.1182/blood.V114.22.797.797

Published: 2009

Journal Articles

Invasive Streptococcus Pneumoniae infection Associated with Hemolytic Uremic Syndrome in Chinese Pediatric Patients

Jason Chi Chiu So, Yuk-Yan Leung, Sze Fai Yip, Clarence CC Lam, Li Chong Chan

Blood (2008) 112 (11): 4586.

https://doi.org/10.1182/blood.V112.11.4586.4586

Published: 2008

Journal Articles

Inhibition of Pulmonary Coagulopathy by Nebulized Natural Anticoagulants during Streptococcus Pneumoniae Pneumonia in Rats

J. J. Hofstra, MD, F. E. van den Boogaard, MD, A. D. Cornet, MD, A. P.J. Vlaar, MD, T. van der Poll, MD, PhD, M. Levi, MD, PhD, M. J. Schultz, MD, PhD

Blood (2008) 112 (11): 3068.

https://doi.org/10.1182/blood.V112.11.3068.3068

Published: 2008

Journal Articles

The Role of Gi Signaling in Hematopoiesis.

Marie Terpager, Hiroshi Kataoka, Ivo Cornelissen, Justin Hamilton, Shaun R Coughlin

Blood (2008) 112 (11): 1402.

https://doi.org/10.1182/blood.V112.11.1402.1402

Published: 2008

Journal Articles

Serious Pulmonary Toxicity with SGN-30 and Gemcitabine, Vinorelbine, and Liposomal Doxorubicin in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL): Cancer and Leukemia Group B (CALGB) 50502

Kristie A. Blum, MD, Jeffrey L Johnson, Sin-Ho Jung, Bruce D. Cheson, MD, Nancy L. Bartlett, MD

Blood (2008) 112 (11): 232.

https://doi.org/10.1182/blood.V112.11.232.232

Published: 2008

Journal Articles

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Dan T. Vogl, Edward A. Stadtmauer, James E. Bradner, Lisa Davis, Martin Carroll, Charles W. Nichols, Doris Shank, Mary Carberry, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Craig B. Thompson, Ravi K. Amaravadi

Blood (2008) 112 (11): 3684.

https://doi.org/10.1182/blood.V112.11.3684.3684

Published: 2008

Journal Articles

Lymphoid Subpopulations and Safety Profile in Untreated-Follicular Lymphoma Receiving Rituximab Monotherapy as Induction and Maintenance Therapy.

S. Bassi, MD, P. Mancuso, DSc, F. Gigli, MD, P. Antoniotti, DSc, P. Bertazzoni, MD, J. Quarna, DSc, D. Laszlo, MD, G. Pruneri, MD, L. Orlando, RN, L. Calabrese, DM, C. Cassatella, DM, F. Bertolini, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 4705.

https://doi.org/10.1182/blood.V108.11.4705.4705

Published: 2006

Journal Articles

A Reduced Capacity To Generate Activated Protein C and the Role of PAI-1 Deficiency on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia.

Tymen Keller, Matthijs van Wissen, Koen van der Sluijs, PhD, Eric van Gorp, PhD, Joost Meijers, PhD, Tom van der Poll, PhD, Harry Buller, PhD, Dees Brandjes, PhD, Marcel Levi, PhD, Victor Gerdes, PhD

Blood (2005) 106 (11): 2134.

https://doi.org/10.1182/blood.V106.11.2134.2134

Published: 2005

Journal Articles

The Use of Recombinant Activated Factor VII for Controlling Bleeding in Pediatric Patients Undergoing Invasive Surgeries.

Ampaiwan Chuansumrit, MD, Sumate Teeraratkul, MD, Sukasom Attanawanich, MD, Pracha Nantnarumit, MD, Suradej Hongeng, MD, Suthep Wanitkun, MD, Junya Jirapradittha, MD, Mali Rungreungvanich, MD, Taweesak Janwityanujit, MD, Teerachai Chantarojanasiri, MD

Blood (2004) 104 (11): 4011.

https://doi.org/10.1182/blood.V104.11.4011.4011

Published: 2004

Journal Articles

Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide

Anita W. Rijneveld, Sebastiaan Weijer, Sandrine Florquin, Charles T. Esmon, Joost C. M. Meijers, Peter Speelman, Pieter H. Reitsma, Hugo Ten Cate, Tom van der Poll

Blood (2004) 103 (5): 1702–1709.

https://doi.org/10.1182/blood-2002-05-1380

Published: 2004

Journal Articles

Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumonia

Anita W. Rijneveld, Sandrine Florquin, Paul Bresser, Marcel Levi, Vivian de Waard, Roger Lijnen, Jaring S. Van der Zee, Peter Speelman, Peter Carmeliet, Tom van der Poll

Blood (2003) 102 (3): 934–939.

https://doi.org/10.1182/blood-2003-01-0227

Published: 2003

NARROW

Real-World Outcomes of Ruxolitinib for Polycythemia Vera

Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Safety, Phamacokinetics (PK), Pharmacodynamics (PD) and Preliminary Activity in Acute Leukemia of Ory-1001, a First-in-Class Inhibitor of Lysine-Specific Histone Demethylase 1A (LSD1/KDM1A): Initial Results from a First-in-Human Phase 1 Study

Burden of Pneumococcal Disease in Cancer Patients: A 20 Year Single Center Study at Memorial Sloan-Kettering Cancer Center

Outcomes of Splenectomy in Children with Sickle Cell Disease

Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine

A Phase II Trial of TBL 12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma,

A Phase II Trial of TBL 12 Sea Cucumber Extract In Patients Withuntreated Asymptomatic Myeloma

Invasive Streptococcus Pneumoniae infection Associated with Hemolytic Uremic Syndrome in Chinese Pediatric Patients

Inhibition of Pulmonary Coagulopathy by Nebulized Natural Anticoagulants during Streptococcus Pneumoniae Pneumonia in Rats

The Role of Gi Signaling in Hematopoiesis.

Serious Pulmonary Toxicity with SGN-30 and Gemcitabine, Vinorelbine, and Liposomal Doxorubicin in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL): Cancer and Leukemia Group B (CALGB) 50502

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Lymphoid Subpopulations and Safety Profile in Untreated-Follicular Lymphoma Receiving Rituximab Monotherapy as Induction and Maintenance Therapy.

A Reduced Capacity To Generate Activated Protein C and the Role of PAI-1 Deficiency on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia.

The Use of Recombinant Activated Factor VII for Controlling Bleeding in Pediatric Patients Undergoing Invasive Surgeries.

Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide

Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumonia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only